These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4674857)

  • 1. [Melphalan therapy in Myelomatosis].
    Ota H; Ikeda Y; Shibata T; Hattori H; Yasuma A
    Rinsho Ketsueki; 1972 Oct; 13(5):811-9. PubMed ID: 4674857
    [No Abstract]   [Full Text] [Related]  

  • 2. [Maintenance therapy with low-dose of melphalan in multiple myeloma (author's transl)].
    Hirasawa Y; Nagaoka T; Kuto F; Tokuhiro H; Kikawada R
    Rinsho Ketsueki; 1980 Nov; 21(11):1646-54. PubMed ID: 7206225
    [No Abstract]   [Full Text] [Related]  

  • 3. [The treatment of myelomatosis with melphalan (author's transl)].
    Hasegawa M; Aoki M; Ogawa T; Imamura Y; Hino S
    Rinsho Ketsueki; 1977 Aug; 18(8):961-72. PubMed ID: 916219
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of myelomatosis with melphalan and testosterone. Some biochemical changes in relation to therapeutics].
    Rordam P; Thiessen B
    Folia Clin Int (Barc); 1966; 16(7):339-41. PubMed ID: 5991648
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple myeloma. Prolonged periods of remission can be produced in myelomatosis with alkylating agents.
    Leone LA; Albala MM
    R I Med J; 1965 Sep; 48(9):478-85. PubMed ID: 5213242
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term treatment of myelomatosis with Melphalan and testosterone propionate].
    Rordam P
    Folia Clin Int (Barc); 1967 Mar; 17(3):148-58. PubMed ID: 5614470
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of myelomatosis].
    Rordam P
    Ugeskr Laeger; 1969 Jan; 131(1):15-9. PubMed ID: 5766707
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prolonged survival in a case of multiple myeloma treated with high dose of melphalan].
    Shibata T; Ikeda Y; Isobe T; Ota H; Nimi M
    Rinsho Ketsueki; 1973 May; 14(5):619-25. PubMed ID: 4738278
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical contribution the the therapy of multiple myeloma with phenylalanine mustard (melphalan)].
    Giardin A; Del Mela P; Morandi GA
    Riv Crit Clin Med; 1966 Aug; 66(3):244-54. PubMed ID: 6002407
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination chemotherapy in Alkeran-resistant myelomatosis].
    Kjølseth I; Wisløff F; Godal HC
    Tidsskr Nor Laegeforen; 1984 May; 104(13):873-4. PubMed ID: 6463973
    [No Abstract]   [Full Text] [Related]  

  • 11. Melphalan and dexamethasone for patients with multiple myeloma who are not candidates for autologous stem cell transplantation.
    Sharma A; Lokeshwar N; Raina V; Mohanti BK; Kumar R
    Natl Med J India; 2007; 20(3):121-4. PubMed ID: 17867615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Melphalan in multiple myeloma].
    Ben-Bassat Y
    Harefuah; 1971 Feb; 80(3):141-3. PubMed ID: 5099255
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic factors and survival in multiple myeloma. Analysis of 91 cases treated by melphalan and prednisone.
    Gobbi M; Cavo M; Savelli G; Baccarani M; Tura S
    Haematologica; 1980 Aug; 65(4):437-45. PubMed ID: 6774915
    [No Abstract]   [Full Text] [Related]  

  • 14. [The treatment of multiple myeloma with melphalan].
    de Halleux F
    Presse Med (1893); 1967 Nov; 75(46):2307-10. PubMed ID: 6054150
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical study on the chemotherapy of multiple myeloma. 1. Therapeutic effect of sequential combination therapy using melphalan, ifosfamide, and prednisolone].
    Sezaki T; Ishii H; Osada T; Adachi T; Takahashi I; Ohnoshi T; Kimura I
    Rinsho Ketsueki; 1982 Jun; 23(6):847-53. PubMed ID: 7176091
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy results and clinical course in 91 cases of multiple myeloma with regard to their clinical staging (author's transl)].
    Rubio Felix D; Giraldo MP; Raichs A; García Zueco JC; Mur P; Faura MV; Ruíz-Marcuello E; Piñan MA
    Sangre (Barc); 1980; 25(1):25-34. PubMed ID: 7384962
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of two-stage treatment of multiple myeloma with melphalan and with melphalan in combination with cyclophosphamide, carmustine, vincristine and prednisone.
    Snigurowicz J; Kraj M; Rostkowska J; Maj S; Mariańska B; Mendek E; Roszkowski S; Kilian Z; Kołakowski L
    Arch Immunol Ther Exp (Warsz); 1981; 29(2):145-53. PubMed ID: 7030265
    [No Abstract]   [Full Text] [Related]  

  • 18. [Multiple myeloma (author's transl)].
    Nakatsuji T; Matsumoto N; Kaku K; Hiroshige Y; Oda S; Shinohara K; Yaga K; Fujii S; Miwa S; Kamei T; Nagasawa T; Tani S
    Rinsho Ketsueki; 1980 Mar; 21(3):347-55. PubMed ID: 7411874
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prognosis in myelomatosis treated with prednisone and cytostatics].
    Hansen OP; Jessen B; Videbaek A
    Ugeskr Laeger; 1973 Jun; 135(23):1169-73. PubMed ID: 4757116
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythroleukemia following melphalan therapy for multiple myeloma.
    Fishman SA; Ritz ND
    N Y State J Med; 1975 Nov; 75(13):2402-4. PubMed ID: 1059018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.